Learn more

GANEDEN BIOTECH INC

Overview
  • Total Patents
    153
  • GoodIP Patent Rank
    49,543
  • Filing trend
    ⇧ 28.0%
About

GANEDEN BIOTECH INC has a total of 153 patent applications. It increased the IP activity by 28.0%. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, foods and drinks and environmental technology are REXALL SUNDOWN INC, AOSA PHARMED LTD and MARINOVA PTY LTD.

Patent filings per year

Chart showing GANEDEN BIOTECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Farmer Sean 144
#2 Lefkowitz Andrew R 56
#3 Keller David 21
#4 Bush Michael 19
#5 Maske David 14
#6 Mikhail Robert J 13
#7 Lefkowitz Andrew 11
#8 Bush Michael A 9
#9 Cash Howard 9
#10 Maske David T 6

Latest patents

Publication Filing date Title
WO2019071193A1 Inactivated bacillus coagulans and uses thereof for reducing stress
CN111278302A Inactivated bacillus coagulans and application thereof in aspect of enhancing physical performance
US2015313951A1 Functional foods containing bacillus coagulans and non-dairy milk-like compositions
AU2015200006A1 Baked Goods
US2015044317A1 Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof
WO2013130829A1 Cosmetic compositions
WO2011130487A1 Probiotic confection and lipid compositions
EP3246039A1 Bacterial cell membrane formulation
BR122017003315B1 Food compositions understanding grains and isolated spaces of bacillus coagulans, as well as their preparation method
US2009305387A1 Compositions and methods for cleaning surfaces
WO2009032121A1 Compositions and methods for enhancing paper product degradation
US2006073130A1 Methods and compositions for the dietary management of autoimmune disorders
US7767203B2 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
AU2003236417B2 Methods For Reducing Cholesterol Using Bacillus Coagulans Spores, Systems And Compositions
US6849256B1 Inhibition of pathogens by probiotic bacteria
CA2389982A1 Inhibition of pathogens by bacillus coagulans strains
WO0113956A2 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
AU7573200A Use of emu oil carrier for antifungal, antibacterial, and antiviral medications
AU4353300A Methods for inhibiting microbial infections associated with sanitary products
US6645506B1 Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil